0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Versican accumulation drives Nos2 induction and aortic disease in Marfan syndrome via Akt activation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Thoracic aortic aneurysm and dissection (TAAD) is a life-threatening condition associated with Marfan syndrome (MFS), a disease caused by fibrillin-1 gene mutations. While various conditions causing TAAD exhibit aortic accumulation of the proteoglycans versican (Vcan) and aggrecan (Acan), it is unclear whether these ECM proteins are involved in aortic disease. Here, we find that Vcan, but not Acan, accumulated in Fbn1 C1041G/+ aortas, a mouse model of MFS. Vcan haploinsufficiency protected MFS mice against aortic dilation, and its silencing reverted aortic disease by reducing Nos2 protein expression. Our results suggest that Acan is not an essential contributor to MFS aortopathy. We further demonstrate that Vcan triggers Akt activation and that pharmacological Akt pathway inhibition rapidly regresses aortic dilation and Nos2 expression in MFS mice. Analysis of aortic tissue from MFS human patients revealed accumulation of VCAN and elevated pAKT-S473 staining. Together, these findings reveal that Vcan plays a causative role in MFS aortic disease in vivo by inducing Nos2 via Akt activation and identify Akt signaling pathway components as candidate therapeutic targets.

          Synopsis

          Thoracic aortic aneurysms and dissections are common in Marfan syndrome (MFS), a disorder resulting from Fibrillin-1 gene mutations. This study investigates the factors associated with MFS-induced aortopathy in mice.

          • The glycoprotein Vcan accumulates in aortas of both MFS mice and patients.

          • Silencing Vcan, but not Acan, reverses aortic disease and restores aortic Nos2 expression in MFS mice.

          • Vcan activates Akt, and pharmacological inhibition of Akt regresses aortic dilatation and decreases Nos2 protein levels in MFS mice.

          • Elevated pAKT-S473 levels were detected in the aortas of MFS patients.

          Abstract

          Thoracic aortic aneurysms and dissections are common in Marfan syndrome (MFS), a disorder resulting from Fibrillin-1 gene mutations. This study investigates the factors associated with MFS-induced aortopathy in mice.

          Related collections

          Most cited references56

          • Record: found
          • Abstract: found
          • Article: not found

          Osteoarthritis as a disease of the cartilage pericellular matrix

          Osteoarthritis is a painful joint disease characterized by progressive degeneration of the articular cartilage as well as associated changes to the subchondral bone, synovium, and surrounding joint tissues. While the effects of osteoarthritis on the cartilage extracellular matrix (ECM) have been well recognized, it is now becoming apparent that in many cases, the onset of the disease may be initially reflected in the matrix region immediately surrounding the chondrocytes, termed the pericellular matrix (PCM). Growing evidence suggests that the PCM – which along with the enclosed chondrocytes are termed the “chondron” – acts as a critical transducer or “filter” of biochemical and biomechanical signals for the chondrocyte, serving to help regulate the homeostatic balance of chondrocyte metabolic activity in response to environmental signals. Indeed, it appears that alterations in PCM properties and cell-matrix interactions, secondary to genetic, epigenetic, metabolic, or biomechanical stimuli, could in fact serve as initiating or progressive factors for osteoarthritis. Here, we discuss recent advances in the understanding of the role of the PCM, with an emphasis on the reciprocity of changes that occur in this matrix region with disease, as well as how alterations in PCM properties could serve as a driver of ECM-based diseases such as osteoarthritis. Further study of the structure, function, and composition of the PCM in normal and diseased conditions may provide new insights into the understanding of the pathogenesis of osteoarthritis, and presumably new therapeutic approaches for this disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders.

            FBN1 encodes the gene for fibrillin-1, a structural macromolecule that polymerizes into microfibrils. Fibrillin microfibrils are morphologically distinctive fibrils, present in all connective tissues and assembled into tissue-specific architectural frameworks. FBN1 is the causative gene for Marfan syndrome, an inherited disorder of connective tissue whose major features include tall stature and arachnodactyly, ectopia lentis, and thoracic aortic aneurysm and dissection. More than one thousand individual mutations in FBN1 are associated with Marfan syndrome, making genotype-phenotype correlations difficult. Moreover, mutations in specific regions of FBN1 can result in the opposite features of short stature and brachydactyly characteristic of Weill-Marchesani syndrome and other acromelic dysplasias. How can mutations in one molecule result in disparate clinical syndromes? Current concepts of the fibrillinopathies require an appreciation of tissue-specific fibrillin microfibril microenvironments and the collaborative relationship between the structures of fibrillin microfibril networks and biological functions such as regulation of growth factor signaling.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              ADAMTS proteins in human disorders

              ADAMTS proteins are a superfamily of 26 secreted molecules comprising two related, but distinct families. ADAMTS proteases are zinc metalloendopeptidases, most of whose substrates are extracellular matrix (ECM) components, whereas ADAMTS-like proteins lack a metalloprotease domain, reside in the ECM and have regulatory roles vis-à-vis ECM assembly and/or ADAMTS activity. Evolutionary conservation and expansion of ADAMTS proteins in mammals is suggestive of crucial embryologic or physiological roles in humans. Indeed, Mendelian disorders or birth defects resulting from naturally occurring ADAMTS2, ADAMTS3, ADAMTS10, ADAMTS13, ADAMTS17, ADAMTS20, ADAMTSL2 and ADAMTSL4 mutations as well as numerous phenotypes identified in genetically engineered mice have revealed ADAMTS participation in major biological pathways. Important roles have been identified in a few acquired conditions. ADAMTS5 is unequivocally implicated in pathogenesis of osteoarthritis via degradation of aggrecan, a major structural proteoglycan in cartilage. ADAMTS7 is strongly associated with coronary artery disease and promotes atherosclerosis. Autoantibodies to ADAMTS13 lead to a platelet coagulopathy, thrombotic thrombocytopenic purpura, which is similar to that resulting from ADAMTS13 mutations. ADAMTS proteins have numerous potential connections to other human disorders that were identified by genome-wide association studies. Here, we review inherited and acquired human disorders in which ADAMTS proteins participate, and discuss progress and prospects in therapeutics.
                Bookmark

                Author and article information

                Contributors
                mcampanero@cbm.csic.es
                jmredondo@cbm.csic.es
                Journal
                EMBO Mol Med
                EMBO Mol Med
                EMBO Molecular Medicine
                Nature Publishing Group UK (London )
                1757-4676
                1757-4684
                2 January 2024
                2 January 2024
                January 2024
                : 16
                : 1
                : 132-157
                Affiliations
                [1 ]GRID grid.467824.b, ISNI 0000 0001 0125 7682, Gene Regulation in Cardiovascular Remodeling and Inflammation Group, , Centro Nacional de Investigaciones Cardiovasculares (CNIC), ; Madrid, 28029 Spain
                [2 ]GRID grid.510932.c, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), ; Madrid, Spain
                [3 ]GRID grid.419651.e, ISNI 0000 0000 9538 1950, Laboratory of Vascular Pathology, , Hospital IIS-Fundación Jiménez Díaz, ; 28040 Madrid, Spain
                [4 ]Cell-Cell Communication & Inflammation Unit, Centro de Biología Molecular Severo Ochoa (CBMSO), Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, ( https://ror.org/03v9e8t09) Madrid, 28049 Spain
                [5 ]Medical University of South Carolina (MUSC), ( https://ror.org/012jban78) Charleston, SC 29425 USA
                [6 ]GRID grid.411325.0, ISNI 0000 0001 0627 4262, Cardiovascular Surgery, , Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Valdecilla (IDIVAL), Facultad de Medicina, Universidad de Cantabria, ; Santander, 39005 Spain
                [7 ]Teknon Medical Centre-Quironsalud. Heart Institute, Barcelona, Spain
                [8 ]Department of Cardiology, Hospital Universitari Vall d’Hebron (VHIR), ( https://ror.org/03ba28x55) Barcelona, 08035 Spain
                Author information
                http://orcid.org/0000-0002-9317-8646
                http://orcid.org/0000-0002-1372-8469
                http://orcid.org/0000-0001-5324-8569
                http://orcid.org/0000-0003-2606-5593
                http://orcid.org/0009-0008-4512-5559
                http://orcid.org/0000-0001-7955-8979
                http://orcid.org/0000-0002-4152-7621
                http://orcid.org/0000-0003-4714-2420
                http://orcid.org/0000-0003-1410-8621
                http://orcid.org/0000-0001-5779-9122
                Article
                9
                10.1038/s44321-023-00009-7
                10897446
                38177536
                b04a6515-375d-4a8c-85d5-0e9df7d602a9
                © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Creative Commons Public Domain Dedication waiver http://creativecommons.org/publicdomain/zero/1.0/ applies to the data associated with this article, unless otherwise stated in a credit line to the data, but does not extend to the graphical or creative elements of illustrations, charts, or figures. This waiver removes legal barriers to the re-use and mining of research data. According to standard scholarly practice, it is recommended to provide appropriate citation and attribution whenever technically possible.

                History
                : 3 April 2023
                : 2 November 2023
                : 10 November 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100004837, Ministerio de Ciencia e Innovación (MCIN);
                Award ID: PID2021-122388OB-100
                Award ID: PID2020-115217RB-100
                Award ID: RTI2018-099246-B-I00
                Award ID: CEX2021-001154-S
                Award ID: CEX2020-001041-S
                Award ID: BES-2016-077649
                Award ID: CD18/00028
                Award ID: IJC2020-044581-I
                Award ID: RYC2021-033343-I
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100010434, 'la Caixa' Foundation ('la Caixa');
                Award ID: HR18-00068
                Funded by: FundRef http://dx.doi.org/10.13039/501100004587, MEC | Instituto de Salud Carlos III (ISCIII);
                Award ID: CB16/11/00264
                Award ID: CB16/11/00479
                Award ID: PI17/00381
                Award ID: PI21/00084
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100008666, Fundació la Marató de TV3 (Fundació la Marató);
                Award ID: 20151330
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100018812, Instituto de Investigación Marqués de Valdecilla (IDIVAL);
                Award ID: INNVAL 21/24
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100010258, Marfan Foundation (The Marfan Foundation);
                Award ID: MRF/1701
                Award Recipient :
                Funded by: Fundacion MERCK-Fundacion Espanola de Enfermedades Raras
                Award ID: Muévete por los que no pueden 2021
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100023561, Ministerio de Universidades (MU);
                Award ID: FPU 20/04814
                Award Recipient :
                Categories
                Article
                Custom metadata
                © European Molecular Biology Organization 2024

                Molecular medicine
                akt; aortic aneurysm; marfan syndrome; nos2; versican,molecular biology of disease,vascular biology & angiogenesis

                Comments

                Comment on this article